Sales decline 8.74% to Rs 159.43 crore
Net loss of SMS Pharmaceuticals reported to Rs 2.01 crore in the quarter ended September 2022 as against net profit of Rs 23.03 crore during the previous quarter ended September 2021. Sales declined 8.74% to Rs 159.43 crore in the quarter ended September 2022 as against Rs 174.70 crore during the previous quarter ended September 2021. ParticularsQuarter EndedSep. 2022Sep. 2021% Var.Sales159.43174.70 -9 OPM %8.5126.78 -PBDT8.9343.33 -79 PBT0.8435.24 -98 NP-2.0123.03 PLPowered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
